Analysis of FTC and Anti-trust Regulations in Biotech Sector

Exploring the implications of FTC scrutiny and anti-trust regulations in the biotech sector, with a focus on operational disruptions and the rarity of second requests. The chapter underscores the multi-faceted nature of deal determinants beyond just FTC oversight.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app